Vomifoliol

CAS: 23526-45-6

Ref. 3D-FV177947

Produktinformation

• Name: Vomifoliol
• Synonyme: (+)-Vomifoliol, (4S)-4-Hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-2-cyclohexen-1-one, (6S,7E,9R)-6,9-Dihydroxy-4,7-megastigmadien-3-one, (6S,9R)-6-Hydroxy-3-oxo-α-ionol, (6S,9R)-Vomifoliol, 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+)-, 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, [S-[R*,S*-(E)]]-, 2-Cyclohexen-1-one, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-butenyl]-3,5,5-trimethyl-, (4S)-, 2-cyclohexen-1-one, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-, (4S)-, Blumenol A, L6V BUTJ C1 DQ D1U1YQ1 E1 E1 & & (4S)-(1E,3R)- Form, Roseoside aglycon

Beschreibung

Vomifoliol is a glycoside derivative of pueraria lobata. It has been shown to have anti-cancer properties in vitro and in vivo. Vomifoliol inhibits the growth of MDA-MB-231 breast cancer cells through p-hydroxybenzoic acid, which binds to the matrix effect and prevents its binding to the receptor. This compound also has anti-inflammatory activities, which are mediated by its ability to inhibit the production of prostaglandins. In addition, vomifoliol is able to induce apoptosis in human kidney cells through intracellular accumulation of reactive oxygen species (ROS).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 224.14124
• Formel: C₁₃H₂₀O₃
• Reinheit: Min. 95%